ProtoKinetix, Inc.
CIK 1128189fmd_1JNMKCBGHR9GGQE365XBQ1KHERManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 24, 1999 to Mar 31, 2026, 74 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | – | – | – |
| Research and development | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 2 | 2 | 1 | 4 | 8 | 2 | 2 | 0 | 0 | 0 |
| Operating income | – | – | – | – | – | – | – | – | – | – |
| Interest expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | – | – | – | – | – | – | – | – | – | – |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | – | – | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Net income | (2) | (2) | (1) | (4) | (8) | (2) | (2) | (0) | (0) | (0) |
| Net income to common shareholders | – | – | – | – | – | (2) | (2) | (0) | – | – |